Table 1 Baseline characteristics of the study population.
n (%) or median (IQR) | Total population n = 879 | No recurrences n = 239 | Only ERAF n = 78 | Only LRAF n = 248 | ERAF and LRAF n = 314 | p-value |
|---|---|---|---|---|---|---|
Age, years | 61 (54–68) | 60 (53–67) | 60 (54–69) | 62 (53–69) | 63 (56–69) | 0.034 |
Males | 560 (64) | 152 (64) | 51 (65) | 167 (67) | 187 (60) | 0.688 |
Persistent AF | 339 (39) | 58 (24) | 27 (35) | 97 (39) | 157 (50) | <0.001 |
BMI, kg/m2 | 28 (25–31) | 28 (25–30) | 28 (25–30) | 28 (26–31) | 28 (26–31) | 0.438 |
BMI ≥30 kg/m² | 290 (33) | 70 (29) | 20 (26) | 89 (36) | 111 (35) | 0.056 |
Hypertension | 649 (74) | 171 (72) | 57 (73) | 178 (72) | 243 (77) | 0.701 |
Diabetes mellitus | 154 (18) | 34 (14) | 10 (13) | 44 (18) | 66 (21) | 0.129 |
Coronary artery disease | 128 (15) | 31 (13) | 6 (8) | 42 (17) | 49 (16) | 0.122 |
Chronic herat failure | 61 (7) | 6 (3) | 4 (5) | 18 (7) | 33 (11) | 0.008 |
Peripheral artery disease | 87 (10) | 18 (8) | 8 (10) | 30 (12) | 31 (10) | 0.110 |
eGFR, ml/min/1.73 m2 | 96 (79–118) | 99 (83–119) | 94 (76–121) | 99 (77–120) | 95 (79–114) | 0.634 |
eGFR <60 ml/min/1.73 m2 | 64 (7) | 9 (4) | 4 (5) | 24 (10) | 27 (9) | 0.006 |
LA diameter (AP), mm | 42 (39–46) | 41 (37–45) | 42 (39–46) | 43 (39–47) | 43 (40–48) | <0.001 |
EF, % | 60 (55–65) | 61 (57–65) | 62 (56–66) | 60 (55–65) | 60 (53–65) | 0.001 |
Bundle brunch block | 60 (7) | 14 (6) | 2 (3) | 19 (8) | 25 (8) | 0.089 |
CHA2DS2-VASc score | 2 (1–3) | 2 (1–3) | 2 (1–3) | 2 (1–3) | 2 (1–3) | 0.004 |
APPLE score | 1 (1–2) | 1 (0–2) | 1 (1–2) | 2 (1–2) | 2 (1–2) | <0.001 |
MB-LATER score | 2 (1–2) | 1 (0–2) | 2 (1–3) | 1 (1–2) | 2 (2–3) | <0.001 |
